Print PDF

Amanda K. Murphy Ph.D.
+1 202 408 4114
amanda.murphy@finnegan.com

901 New York Avenue, NW
Washington, DC 20001-4413

+1 202 408 4000
Fax +1 202 408 4400

Bar and Court Admissions

  • District of Columbia
  • Virginia
  • U.S. Court of Appeals, Federal Circuit
  • U.S. Patent and Trademark Office

Education

  • Georgetown University Law Center
    J.D., cum laude, 2010
  • Cornell University
    Ph.D., Biochemistry, Molectular and Cellular Biology, 2006
  • Cornell University
    B.S., Biology, Concentration in Biochemistry, Molecular and Cellular Biology, 1998

Judicial Clerkships

    U.S. Court of Appeals, Federal Circuit

Amanda K. Murphy Ph.D.

Associate

Amanda Murphy focuses her practice on strategic client counseling, portfolio management, and patent prosecution for a range of clients, including small startup companies, research foundations, and large biotechnology and pharmaceutical companies. She provides patentability opinions, prepares new patent applications, prosecutes U.S. and foreign applications, and represents appellants before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO). Dr. Murphy has experience in prosecuting inter partes and ex partes reexamination applications, reissue applications, and patent term extension applications for approved pharmaceuticals, including obtaining supplemental protection certificates in Europe.

In addition to her patent counseling and prosecution practice, Dr. Murphy handles various litigation matters, including preparing claim construction positions and briefs, working with experts, responding to written discovery, and developing infringement and validity opinions. She also provides strategic advice and pre-litigation analysis and prepares freedom-to-operate, enforceability, infringement opinions, and petitions for inter partes review (IPR).

Dr. Murphy's technical experience includes anticancer agents, antibiotic susceptibility, antibodies, antiretrovirals, antipsychotics, bioethanol technology, biologics, blood clotting factors, cosmetics, diagnostic and detection systems, nucleic acid and protein technologies, Raman spectroscopy, recombinant organisms, small molecules, and vaccines.

Prior to joining Finnegan, Dr. Murphy received her Ph.D. from Cornell University, where she studied the molecular requirements for protein-lipid interactions during retroviral assembly and the lipid compositions of retroviral particles. She then gained significant experience as a technical specialist and a student associate at Finnegan during her studies in law school.

Highlights

  • Member of team representing AbbVie Inc. in Hatch-Waxman litigations over AbbVie's HIV treatments, Norvir® and Kaletra®.
  • Capsugel Belgium NV v. Innercap Technologies, Inc. (PTAB). Represented Capsugel as petitioner; an IPR was instituted and an adverse judgment against Innercap was entered by the PTAB.
  • Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals (E.D. Pa., Fed. Cir.). Member of litigation team that successfully defended Avid (a subsidiary of Eli Lilly and Company), resulting in a jury verdict that plaintiff did not own the patents in suit. Also assisted with the subsequent successful appeal to the Federal Circuit.
  • Serves as an adjunct professor teaching a patent prosecution practice class at Georgetown University Law Center, 2013-present.
  • Former law clerk to the Honorable S. Jay Plager on the U.S. Court of Appeals for the Federal Circuit, 2011-2012.

Professional Activities

  • American Intellectual Property Law Association
  • American Chemical Society
  • Alpha Chi Sigma

Select Publications